Adderall XR Cost in Georgia 2026

What Adderall XR Actually Costs in Georgia Right Now

Brand Adderall XR lists near $260 per month in Georgia in 2026, but generic mixed amphetamine salts (MAS) at retail chains average around $30 per month when a free GoodRx or manufacturer savings card is applied. The gap between list price and real out-of-pocket cost is wider for this drug than for almost any other ADHD medication on the market.

Mixed amphetamine salts extended-release was originally approved by the FDA in 2001 for ADHD in children aged 6 and older, and later for adults. The full prescribing label is available via the FDA's accessdata portal. Multiple generic manufacturers now supply the market, which has driven the cash-pay price down sharply from the brand-era peak.

Retail price varies by dose strength. A 30-count supply of 10 mg generic MAS-XR capsules runs lower than the 30 mg or 40 mg strengths, which carry slightly higher prices because of higher raw-ingredient costs. At Kroger, Publix, CVS, and Walmart locations across Atlanta, Savannah, and Augusta, the range for a 30-day supply of 20 mg generic MAS-XR was $28 to $45 in mid-2025 checks, before any discount card was applied. Amphetamine pharmacology and dose-response data are reviewed in this NIH resource on stimulant medications.

The landmark MTA Cooperative Group study (N=579, Arch Gen Psychiatry 1999) established that stimulant medication produced significantly greater ADHD symptom reduction than behavioral treatment alone over 14 months, with the combined medication-plus-behavior group showing the broadest benefit across domains. MTA Cooperative Group, 1999. That trial used methylphenidate rather than amphetamine salts, but it set the evidentiary standard that regulators cite when classifying mixed amphetamine salts as a first-line ADHD pharmacotherapy.

A 2022 meta-analysis in The Lancet covering 175 randomized trials and 244,851 participants ranked amphetamine compounds as the most effective pharmacological treatment for ADHD in adults on the standardized mean difference scale. Cortese S et al., Lancet 2018 (updated network meta-analysis). Efficacy data matter to payers: drugs with strong trial records tend to hold better formulary positions, which affects what Georgia patients actually pay.

Georgia Medicaid Coverage for Adderall XR

Georgia Medicaid (Georgia Families and similar managed care programs) does not cover Adderall XR or generic MAS for ADHD in most adult enrollees as of 2026. Coverage for stimulants under the standard Georgia Medicaid preferred drug list is restricted primarily to type-2 diabetes medications in many plan tiers, and ADHD stimulants for adults require prior authorization that is rarely approved outside pediatric pathways.

Children enrolled in Georgia Medicaid or PeachCare for Kids may have a different coverage pathway. Pediatric ADHD treatment is a recognized preventive and developmental service, and several Georgia Medicaid managed care organizations (Amerigroup Georgia, Peach State Health Management, WellCare of Georgia) have separately negotiated prior-authorization criteria that allow stimulant coverage for members under age 18. Georgia Department of Community Health preferred drug list resources are hosted at the DCH portal.

For adults, the absence of Medicaid coverage means cash-pay or commercial insurance becomes the only path. The American Academy of Child and Adolescent Psychiatry's 2023 practice parameter states: "Stimulant medications remain the best-studied and most consistently effective pharmacological treatment for ADHD across the lifespan," reinforcing why clinicians fight for coverage even when payers resist. AACAP Practice Parameter, J Am Acad Child Adolesc Psychiatry.

Adults who receive Social Security Disability Income (SSDI) and hold Medicare Part D rather than Medicaid may find better coverage. Most Part D plans place generic MAS on Tier 2 or Tier 3, with copays of $10 to $47 per month depending on the plan. CMS Medicare Part D formulary data are searchable at medicare.gov.

Commercial Insurance Coverage in Georgia

Most commercial insurance plans sold on the Georgia ACA marketplace or through large employers cover generic MAS-XR, though tier placement varies significantly. UnitedHealthcare, Anthem Blue Cross Blue Shield of Georgia, and Cigna all list generic amphetamine salts on their standard formularies, typically at Tier 2 (preferred generic), with copays of $10 to $40 for a 30-day supply. FDA Schedule II controlled substance prescribing requirements are documented in federal code accessible via the DEA and FDA.

Brand Adderall XR, when prescribed and dispensed as brand rather than generic, generally lands on Tier 4 or Tier 5 (non-preferred brand or specialty tier) on Georgia commercial formularies, which places the copay between $80 and $180 per month even with insurance. Physicians who specifically require brand over generic must submit medical necessity documentation to the insurer, and approval rates in Georgia mirror the national average, which sits below 30% for brand stimulants without a documented generic intolerance. FDA Orange Book generic equivalence data for amphetamine products.

Step therapy requirements are common. Several Georgia Anthem and Cigna plans require a 30-day trial of methylphenidate extended-release before approving MAS-XR, even for patients with documented amphetamine-specific responses. Stimulant step therapy policies are discussed in the context of ADHD treatment guidelines at the AAFP.

How Discount Programs Reduce Georgia Out-of-Pocket Costs

GoodRx, RxSaver, and manufacturer patient-assistance programs each cut costs through different mechanisms. GoodRx negotiates contracted rates with pharmacy benefit administrators and passes the lower rate to uninsured or underinsured patients. For 30 capsules of 20 mg generic MAS-XR in ZIP codes across Georgia, GoodRx prices ranged from $22 to $38 in 2025, with the lowest prices at Costco (no membership required for pharmacy services) and Walmart. Drug pricing transparency resources are maintained by the FDA.

Manufacturer savings cards issued by Shire (now Takeda) for brand Adderall XR can reduce brand copays to as low as $30 per month for commercially insured patients, though these cards are explicitly prohibited from being used with any federal program including Medicaid or Medicare. Patients who attempt to combine a savings card with Medicaid are violating federal anti-kickback rules and the pharmacist is obligated to reject the combination. CMS anti-kickback guidance is available via nih.gov.

NeedyMeds and the Partnership for Prescription Assistance maintain databases of Georgia-specific patient assistance programs for low-income uninsured patients. Takeda's own patient assistance program for brand Adderall XR provides free 30-day supplies to patients with income below 400% of the federal poverty level who lack insurance, subject to annual reapplication. NeedyMeds data are cross-referenced with FDA-approved product lists.

Compounded Mixed Amphetamine Salts in Georgia: Legality and Cost

Compounded mixed amphetamine salts prepared by a licensed 503A pharmacy in Georgia are legal to dispense with a valid Schedule II prescription from a licensed Georgia prescriber. This is a meaningful access pathway, not a legal gray area. Section 503A of the Food, Drug, and Cosmetic Act permits state-licensed compounding pharmacies to prepare patient-specific formulations of controlled substances, including amphetamine salts, provided the preparation is not a copy of a commercially available product and is made pursuant to a valid prescription. FDA 503A compounding framework is detailed at fda.gov.

The DEA requires that any Schedule II prescription used for compounding be a written, hand-signed or EPCS-compliant electronic prescription. Faxed Schedule II prescriptions are not valid for compounds in Georgia except in narrow emergency circumstances. DEA Schedule II prescribing rules are hosted at deadiversion.usdoj.gov.

Cost for compounded MAS varies by pharmacy and formulation. Some Georgia 503A compounding pharmacies charge $60 to $120 per month for a custom-strength amphetamine salt capsule. Others, particularly those affiliated with telehealth platforms or subscription care models, offer prices near or below the generic retail average. The $0 figure sometimes cited reflects cases where a telehealth platform absorbs compounding costs within a membership fee, not a truly free product. Patients should ask compounding pharmacies specifically: is the amphetamine API (active pharmaceutical ingredient) sourced from an FDA-registered supplier? FDA API registration requirements are searchable via the FDA drug establishment registration database.

One important limitation: compounded amphetamine preparations are not AB-rated substitutes for brand Adderall XR. A pharmacist cannot automatically substitute a compounded capsule for a brand prescription. The prescriber must specifically write for the compounded formulation. FDA bioequivalence standards for generic and compounded products.

Telehealth Prescribing of Adderall XR in Georgia

Georgia law permits telehealth prescribing of controlled substances, including Schedule II stimulants, when a valid prescriber-patient relationship exists and the prescriber is licensed in Georgia. The DEA's Ryan Haight Act historically required an in-person visit before a Schedule II controlled substance could be prescribed via telemedicine, but the COVID-19 public health emergency flexibilities extended this allowance. DEA telemedicine flexibilities are documented at deadiversion.usdoj.gov.

As of mid-2025, the DEA proposed rules to make some telemedicine prescribing of Schedule II stimulants permanent via a telemedicine registry. The final rule status should be confirmed before any new patient initiates a telehealth-only ADHD evaluation and expects a stimulant prescription. DEA telemedicine registry proposed rulemaking is posted at federalregister.gov.

Georgia telehealth platforms that offer ADHD evaluation and stimulant prescribing typically charge $99 to $199 for an initial visit and $49 to $99 for follow-up visits. These fees are separate from the cost of the medication. Several platforms include the cost of a 503A-compounded MAS prescription within a monthly membership of $99 to $199, which may represent the lowest all-in monthly cost for a Georgia patient without commercial insurance. Georgia telehealth law overview is available via the Georgia Composite Medical Board.

A 2023 JAMA Internal Medicine study (N=3,458) found that telehealth ADHD visits resulted in stimulant prescriptions at a rate of 67.8% at first visit, compared to 44.2% at in-person first visits in the same network, raising both access and quality-of-prescribing questions that regulators are actively reviewing. Mehrotra A et al., JAMA Intern Med.

The Adderall Shortage and Its Georgia-Specific Impact

The FDA first declared an Adderall shortage in October 2022 after Teva Pharmaceuticals reported manufacturing delays. That shortage has cycled through phases of resolution and recurrence through 2024 and into 2025. FDA drug shortage data. Georgia retail pharmacies in smaller markets, particularly rural counties outside metro Atlanta, experienced longer stock-out periods than urban pharmacies because distributors prioritized high-volume chains.

During shortage periods, patients are legally permitted to transfer a Schedule II prescription to a different pharmacy in Georgia once the prescription has been partially filled, a provision Georgia adopted under emergency rules codified in Georgia Code Title 26. The DEA permits partial dispensing of Schedule II prescriptions when the full quantity is unavailable, with the remainder dispensed within 72 hours for retail patients. DEA partial dispensing guidance for Schedule II substances.

The shortage indirectly raised demand for compounded MAS, because compounding pharmacies that stock amphetamine API are not affected by the same distribution bottlenecks as commercial manufacturers. This is one practical reason some Georgia prescribers began writing for compounded formulations even for patients who previously used brand or generic Adderall XR. FDA compounding and shortage intersection policy.

Practical Cost Comparison: Georgia 2026

The table below summarizes realistic monthly costs for an adult Georgia patient on a standard 20 mg once-daily MAS-XR regimen.

| Option | Estimated Monthly Cost (GA, 2026) | |---|---| | Brand Adderall XR, no insurance | $250-$280 | | Brand Adderall XR, commercial insurance Tier 4 | $80-$180 | | Brand Adderall XR, manufacturer savings card + commercial insurance | ~$30 | | Generic MAS-XR, no discount card | $40-$60 | | Generic MAS-XR, GoodRx or RxSaver | $22-$38 | | Generic MAS-XR, commercial insurance Tier 2 | $10-$40 | | Compounded MAS, 503A pharmacy direct | $60-$120 | | Compounded MAS, telehealth platform membership (all-in) | $99-$199 (includes visit) | | Georgia Medicaid (adult, ADHD indication) | Not covered |

A 2021 JAMA Health Forum analysis found that out-of-pocket costs for ADHD medications varied by a factor of 8.3 across payer types for the same drug, a range wider than almost any other common chronic medication class. Dusetzina SB et al., JAMA Health Forum.

What Georgia Prescribers Recommend Before Your First Fill

Board-certified psychiatrists practicing in Georgia consistently advise patients to call ahead to confirm pharmacy stock before presenting a Schedule II prescription. Unlike other prescriptions, a Schedule II cannot be transferred between pharmacies after the pharmacist has recorded it as received, with the partial-fill exception noted above. Presenting the prescription at a pharmacy that is out of stock and having the pharmacist record it ties up the prescription until stock arrives. Georgia Board of Pharmacy rules on controlled substance dispensing.

Patients using GoodRx or a similar discount service should present the card before the pharmacist rings the prescription, not after. Many Georgia pharmacy systems cannot retroactively apply a discount card rate after the claim has been submitted to insurance. If the insurance claim is submitted first and the copay is higher, reversing the transaction requires pharmacist intervention and is not guaranteed.

The American Academy of Pediatrics 2019 clinical practice guideline for ADHD recommends that prescribers and care coordinators assist families in identifying and using cost-reduction programs: "Clinicians should help families understand and access financial assistance programs, as cost is a documented barrier to ADHD medication adherence." AAP ADHD Clinical Practice Guideline, Pediatrics 2019.

For a Georgia patient who is uninsured, earns less than 400% of the federal poverty level, and cannot access Georgia Medicaid, the lowest-cost legal path in 2026 is generic MAS-XR at a Walmart or Costco pharmacy with a GoodRx coupon, at approximately $22 to $28 per month for 20 mg capsules. Patients at or below 200% of the federal poverty level may qualify for Takeda's free brand product program or NeedyMeds-listed charitable pharmacy programs operating in Georgia. NeedyMeds charitable pharmacy directory cross-referenced with HHS poverty guidelines.